19 20 22 We identified five potential barriers to effective PrEP use: interpreting effectiveness; managing adherence; PrEP candidacy and low perceptions of HIV risk; concerns with other risks such as the criminalisation of HIV transmission and sexually transmitted infections (STIs); and moral barriers.
Respondents are also asked if they make use of any practitioner guidelines to manage patient adherence.
Attitudes towards LAI antipsychotics compared with oral medications were generally positive; most HCPs surveyed agreed that LAI antipsychotics allowed intervention to address non-adherence (83% agreed) and provided the best way to manage non-adherence due to poor insight (87% agreed).
In particular, statements gaining the most agreement were that LAI antipsychotics allow intervention to address non-adherence (83% agreed), adherence advantages of LAI antipsychotics ensure a lower rate of relapse (87% agreed), and that LAI antipsychotics provide the best way to manage non-adherence due to poor insight (80% agreed).
Once patients have been tested and placed on treatment, there will be the challenge of managing patient adherence and change in risky behavior.
In fact, the U.S. costs of managing poor adherence have been estimated to be as much as $100 billion annually [ 2, 3, 6].
HIV is increasingly characterized as a chronic condition that can be managed through adherence to a healthy lifestyle, complex drug regimens, and treatment monitoring; however, a person's housing status can be a significant determinant of an individual's ability to meet these requirements and achieve better health status (7).
This was primarily due to the purchasing cost every 3 years ($120 per cap/bottle unit; the battery life limits the length of use) but also due to the additional expected input from the pharmacist (annual wage $37,341) and pharmacist assistant (annual wage $8,487) in managing the adherence measurement process.
77 The implementation of the test-and-treat strategy will produce a rapid decline in HIV incidence and mortality and thus a shift in focus, from ensuring that everyone infected is placed on treatment to managing patient adherence and minimizing transmitted resistance.
